Protocol Ledger

NCT04533997 · Phase III · COMPLETED

Hypertonic Saline Therapy in Ambulatory Heart Failure Unit.

Interventional Phase III clinical trial protocol NCT04533997 sponsored by Puerta de Hierro University Hospital in Cardiovascular and Thrombosis, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2021-01-01 Enrollment: 167 participants (ACTUAL) Federal Source: clinicaltrials.gov/study/NCT04533997
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)167 participants (ACTUAL)
Disclosed U.S. Hospital Campuses vs Median (6 sites)1 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT04533997
Protocol FieldVerified Registry Value
NCT IdentifierNCT04533997
Consolidated Lead SponsorPuerta de Hierro University Hospital
Therapeutic Condition CohortCardiovascular and Thrombosis
Clinical Trial PhasePhase III
Overall Recruitment StatusCOMPLETED
Registered Enrollment167 participants (ACTUAL)
Registered Start Date2021-01-01
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT04533997
Hospital Research SiteLocationSite Profile
Hospital Universitario Ramón y CajalMadrid, SpainOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Cardiovascular and Thrombosis Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI